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Abstract  20 
 21 
CRISPR-Cas immune systems are widespread in bacteria and archaea, but not 22 
ubiquitous. Previous work has demonstrated that CRISPR immunity is associated with 23 
an infection-induced fitness cost, which may help explain the patchy distribution 24 
observed. However, the mechanistic basis of this cost has remained unclear. Using 25 
Pseudomonas aeruginosa PA14 and its phage DMS3vir as a model, we perform a 30-day 26 
evolution experiment under phage mediated selection. We demonstrate that although 27 
CRISPR is initially selected for, bacteria carrying mutations in the phage receptor 28 
rapidly invade the population following subsequent reinfections. We then test three 29 
potential mechanisms for the observed cost of CRISPR: i) autoimmunity from the 30 
acquisition of self-targeting spacers, ii) immunopathology or energetic costs from 31 
increased cas gene expression and iii) toxicity caused by phage gene expression prior to 32 
CRISPR mediated cleavage. We find that phages can express genes before the immune 33 
system clears the infection and that expression of these genes can have a negative effect 34 
on host fitness. While infection does not lead to increased expression of cas genes, it does 35 
cause differential expression of multiple other host processes that may further 36 
contribute to the cost of CRISPR immunity. In contrast, we found little support for 37 
infection-induced autoimmunological and immunopathological effects. Phage gene 38 
expression prior to cleavage of the genome by the CRISPR-Cas immune system is 39 




CRISPR-Cas immune systems exhibit a widespread, but patchy, distribution in bacteria and 44 
archaea [1, 2]. This distribution is indicative of extensive gain and loss of such adaptive 45 
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immune systems with high predicted rates of horizontal gene transfer [3–5]. Such gain or loss 46 
is likely the result of the balance between potential benefit, i.e. the targeting of phages and 47 
deleterious mobile genetic elements (MGEs) against the cost of carriage and expression [6, 48 
7]. Put differently, fitness trade-offs associated with CRISPR immunity may select for 49 
alternative resistance strategies and the subsequent loss of CRISPR [8].  Previous work has 50 
demonstrated that the cost of CRISPR immunity against lytic phage can be inducible, where 51 
the cost is only realised upon phage infection [9, 10]. As a consequence, CRISPR immunity 52 
is only favoured over loss or mutation of the phage receptor at a low frequency of infection. 53 
In contrast, when infection risk is high, a constitutive defence, mutation of the phage 54 
receptor, is selected for since this is associated with a fixed cost that does not change, 55 
regardless of the number of encounters with phages [9]. 56 
 57 
Despite this understanding of the ecological conditions under which different strategies of 58 
resistance will be selected for, the mechanistic basis of the inducible cost of CRISPR 59 
immunity remains unclear [9, 11]. Using Pseudomonas aeruginosa strain PA14 and its lytic 60 
phage DMS3vir, we perform a 30-day evolution experiment that supports the previously 61 
reported inducible cost of CRISPR immunity and then test hypotheses that have been 62 
proposed to explain this cost. Firstly, a cost of autoimmunity, where bacteria acquire self-63 
targeting spacers during infections has been demonstrated in a number of systems and 64 
provides a plausible mechanistic basis for a cost of CRISPR immunity [12–15], although 65 
diverse mechanisms exist to avoid self-targeting spacer acquisition [16]. Ultimately the 66 
relative importance of such self-targeting events at the population level is unknown [17].  67 
 68 
Secondly, a cost of enhanced expression of the CRISPR-Cas immune system following 69 
infection could also explain the induced fitness cost. Amongst a range of different cues that 70 
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regulate CRISPR expression (reviewed in [18]), infection can trigger upregulation of cas 71 
genes and CRISPR arrays [19–21]. Enhanced expression presumably elevates the levels of 72 
protection but would likely be associated with a metabolic cost to the host.  73 
 74 
The final proposed mechanism behind an inducible cost of CRISPR immunity is that 75 
expression of phage-encoded genes may take place prior to clearance of the infection, 76 
whereby the phage genome no longer has a deleterious effect on the host, which could be 77 
harmful to the host [22]. For example, phage can encode anti-CRISPR proteins which must 78 
be expressed before clearance by the immune system in order to function. Anti-CRISPRS are 79 
widespread, show a diversity of functions and are expressed rapidly upon infection [23–25]. 80 
It is therefore likely that other phage genes may also be expressed prior to clearance. Here we 81 
employ a combination of selection experiments, deep sequencing of CRISPR amplicons 82 
following phage infection and RNA sequencing approaches to explore the importance of each 83 
of these three non-mutually exclusive mechanisms in determining the induced fitness cost of 84 
CRISPR-Cas immune systems. Here we use extended evolution experiments that span 30 85 




Materials and methods 90 
Bacterial strains and phages 91 
The previously described P. aeruginosa strains UCBPP-PA14, isogenic mutant Δcas1 and 92 
phage DMS3vir have been previously described [26] and were used throughout this study. 93 
DMS3vir is a modified version of DMS3 that carries a truncated C-repressor, preventing 94 
lysogeny [26]. A variant of DMS3vir, known as DMS3mvir, which carries a modified 95 
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protospacer such that it is targeted by WT PA14, was used for the Δcas1 competition 96 
experiments and has been described previously [26]. Additionally, a variant of PA14 was 97 
used that carries 2 spacers targeting DMS3vir (BIM2 herein) has been described previously 98 
[9] and was used for competition experiments and gene expression profiling. A mutant of 99 
DMS3vir with the full acr operon, including the acrIE3 and aca1 genes and their promoter 100 
sequence, removed has previously been described in [27].   101 
 102 
Evolution experiment 103 
The evolution experiment was performed with 6 replicates by inoculating 6 ml M9 104 
supplemented with 0.2% glucose with approximately 106 bacteria from an overnight cultures 105 
of the WT strain and adding 107 pfu of DMS3vir, followed by incubation at 37 ºC while 106 
shaking at 180 rpm. Cultures were transferred daily 1:100 for 30 days. The ancestral phage 107 
(107 pfu) was added daily to maintain selection for resistance and to constantly induce the 108 
cost of CRISPR immunity. 109 
 110 
Immunity and resistance profiling 111 
Bacterial immunity against the ancestral phage was determined as described before [9, 11, 112 
22] by streaking individual clones (24 clones per sample) through ancestral phage DMS3vir 113 
and phage DMS3vir carrying the anti-CRISPR F1 (acrIF1) gene. Bacterial clones sensitive to 114 
both phages were scored as “sensitive”, those resistant to DMS3vir but sensitive to 115 
DMS3vir+AcrIF1 were scored as “CRISPR immune”, and bacterial clones resistant to both 116 
phages were scored as “surface mutants”. CRISPR-Cas-mediated immunity was further 117 
confirmed by PCR (see table S1 for primers). Surface modification was further confirmed on 118 
the basis of colony morphology (since phage DMS3vir is pilus-specific, surface mutants have 119 
motility defects, resulting in a modified colony morphology) and a lack of new CRISPR 120 
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spacers. From these analyses fractions of each phenotype (sensitive, CRISPR immune, 121 
surface mutant) were calculated for each replicate experiment. 122 
 123 
Δcas1 Competition assays 124 
Relative fitness of bacterial populations with CRISPR-mediated immunity was determined by 125 
direct competition with a surface mutant for 3 days. Competitions were carried out using 126 
blue-white colony screening between a lacZ marked surface mutant and either the WT PA14 127 
or a PA14 mutant that lacks the cas1 gene. We performed 8 replicate experiments of each 128 
competition and used a gradient of phage titres (0, 106, 107 and 108 PFU / mL, n = 64). The 129 
phage used (DMS3mvir) is a mutant of DMS3vir that is targeted by both the WT PA14 and 130 
the Δcas1 strain.  131 
For competition assays, an overnight culture was grown of each strain and a marked surface 132 
mutant. Mixtures were made at a 50:50 ratio and plated at T0. These mixtures were added to 133 
6mL M9 media supplemented with 0.2% glucose and serially transferred with a 1:100 134 
dilution. Populations were plated after 3 days on LB agar supplemented with 30 μg of X-gal 135 
to determine the relative frequencies of the competing strains. Selection coefficients were 136 
determined as described in [11].  137 
 138 
Amplicon Sequencing 139 
In order to track the changes in genetic diversity of the CRISPR loci, we deep sequenced both 140 
CRISPR arrays (CRISPR1 and CRISPR2) from each population described above (see 141 
“evolution experiment”) at 2,4, 6, 10 and 12 days. Full bacterial genomic DNA was isolated 142 
using the Qiagen QIAmp DNA mini kit as per the manufacturer’s protocols. A PCR 143 
amplification was performed for both CRISPR arrays (CRISPR1 and CRISPR2, see table S1 144 
and S2). PCR reactions contained 5 μl DreamTaq master mix (ThermoScientific, UK), 0.5 μl 145 
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forward primer, 0.5 μl reverse primer, 1.5 μl MiliQ water, 0.5 μl DMSO, 2 μl template DNA. 146 
Sample purity was determined by NanoDrop and DNA concentrations were quantified done 147 
using a Qubit fluorometer (ThermoFisher, UK). Two separate CRISPR primer (CRISPR1 and 148 
CRISPR2 locus) pairs were designed for two first round PCRs. 2 μl of DNA was used in a 149 
first-round of PCR. The primer design incorporates a recognition sequence to allow a 150 
secondary nested PCR process (table S2). Samples were first purified with Ampure SPRI 151 
Beads before entering the second PCR performed to incorporate Illumina adapter sequences. 152 
Samples were purified using Ampure SPRI Beads before being quantified using Qubit and 153 
assessed using the Fragment Analyzer. Successfully generated amplicon libraries were taken 154 
forward and pooled in equimolar amounts, then size selected on a Pippin prep using a range 155 
of 180-600bps. The quantity and quality of each pool was assessed by Bioanalyzer and 156 
subsequently by qPCR using the Illumina Library Quantification Kit from Kapa on a Roche 157 
Light Cycler LC480II according to manufacturer's instructions. Template DNA was 158 
denatured according to the protocol described in the Illumina cBot User guide and loaded at 159 
12.5 pM concentration. To help balance the complexity of the amplicon library 15% PhiX 160 
was spiked in. The sequencing of each pool was carried out on one lane of an Illumina 161 
MiSeq, at 2x250 bp paired-end sequencing with v2 chemistry. 162 
 163 
Bioinformatics analysis 164 
Sequence Quality Control 165 
Base-calling and de-multiplexing of indexed reads was performed by CASAVA (version 166 
1.8.2) (Illumina) to produce 30 samples. FASTQ files were trimmed to remove Illumina 167 
adapter sequences using Cutadapt version 1.2.1 [28]. The option “-O 3” was set, so the 3' end 168 
of any reads which matched the adapter sequence over at least 3 bp was trimmed off. The 169 
reads were further trimmed to remove low quality bases, using Sickle version 1.200 with a 170 
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minimum window quality score of 20. After trimming, reads shorter than 10 bp were 171 
removed. The raw reads were subjected to a Cutadapt trimming step to remove PCR primer 172 
sequences that could potentially introduce an artificial level of complexity in the samples. To 173 
improve base quality in both read pairs, sequencing errors were corrected in both forward and 174 
reverse reads using the error-correct module within SPAdes sequence assembler, version 175 
3.1.0 [29]. Read pairs were aligned to produce a single sequence for each pair that would 176 
entirely span the amplicon using PEAR (version 0.9.10; [30]. Additionally, sequences with 177 
uncalled bases (Ns) were removed. To remove sequences originating from potential PCR 178 
primer dimers or from any spurious amplification events, a size selection was applied to each 179 
merged sequence set, respectively between 30-140bp for CRISPR1 and 70-500bp for 180 
CRISPR2. Fragmented PhiX phage genome was added to the sequence library in order to 181 
increase the sequence complexity. To remove any ‘bleed through’ of PhiX sequences, each 182 
sample was compared with the complete PhiX sequence (GenBank gi9626372) using 183 
BLASTN [31]. Sequences matching PhiX (E-value < 10-5) were filtered out of the dataset. 184 
 185 
Clustering and diversity metrics 186 
For each dataset, any sequences passing the filters (from any sample) were merged into a 187 
single file. This final sequence file, plus its own metadata file describing each sample, was 188 
used for the analysis by using a custom pipeline based on QIIME 1.9.0 [32]. Clusters were 189 
defined using SWARM [33], using the strictest (default) parameters. This tool aggregates a 190 
sequence to a cluster if the sequence shows similarity with any of the sequences already 191 
present in that cluster. Importantly, the similarity threshold is not fixed but defined within the 192 
dataset. A minimum cluster size filter is applied to retain clusters containing at least 2 193 
sequences and potential chimeric-sequences due to PCR events were discarded as well. To 194 
calculate the abundance of each cluster, sequences were then aligned on the centroid 195 
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sequence identified for each cluster, using a minimum similarity threshold of 99% for the 196 
entire length of the sequence using the 'usearch_global' function in VSEARCH. 197 
 198 
The sequencing depth of all samples was explored using the ‘Chao 1’ [34] richness index 199 
plotted as a rarefaction curve. Counts in the cluster abundance tables were repeatedly sub-200 
sampled (rarefied; 33 repetitions) at sampling depths of 1000, 12000, 22000, … 150000. The 201 
average Chao1 value obtained by repeating the test 33 times is assigned as alpha-diversity at 202 
that specific number of reads for that sample implemented in Qiime. Because all samples 203 
reached a clear asymptote, i.e. no samples were under-sampled with regards to spacer 204 
diversity, rarefaction was not applied. An abundance table for each locus was used to 205 
estimate the richness and evenness of the samples using the following estimators: total 206 
observed sequence variants, Shannon, Simpson, Simpson evenness again conducted with 207 
Qiime. 208 
 209 
The resulting spacers were extracted from the clustered contigs via CRISPRdetect [35] and 210 
mapped to the phage and host genome. CRISPRtarget [36] was also used to identify spacers 211 
that mapped to the host genome.  212 
 213 
Gene expression profiling 214 
Ten replicate cultures of PA14 BIM2 and 5 of WT were grown overnight in shaken glass 215 
vials (180 RPM) of 6 mL LB media at 37 C then standardized to an optical density of 0.5 216 
OD600 (approx. 2 X 10^9 CFU / mL). Five cultures of BIM2 and 5 cultures of WT were 217 
inoculated with 8 X 10^9 PFU (in 500 uL) DMS3vir (MOI 0.5). 5 cultures of BIM2 remained 218 
uninfected as controls. All replicates were vortexed then incubated statically. After 35 219 
minutes, 1 hour and 2 hours, 1.5 mL of cells were pelleted and snap-frozen at – 80 C. For 220 
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RNA extraction, 1 mL of TRIzol reagent was added immediately after removal from the 221 
freezer. The PureLink RNA mini extraction kit (Invitrogen) was used following instructions 222 
for use with TRIzol and the on-column PureLink DNase treatment (Invitrogen). All protocols 223 
followed the manufacturer’s instructions except for a substitution of 100 μL BCP instead of 224 
chloroform for phase separation. Sample quantities, purities and size distribution were 225 
quantified by Qubit, nanodrop and TapeStation respectively. 150bp libraries were prepared 226 
with the TruSeq directional kit, following manufacturer’s instructions, and sequenced on an 227 
Illumina NovaSeq at Exeter University sequencing centre.  228 
 229 
The resulting reads were quality filtered using Sickle ([37] default settings, version 1.33) with 230 
approx. 6 million read pairs per sample remaining. These were subsequently mapped to the 231 
PA14 and DMS3vir reference genomes with bwa ([38] default settings, version 0.7.17). The 232 
resulting read alignments were assigned to genomic features and counted using HTSeq 233 
(version 0.11.2, [39] using ‘union’ mode,  non-unique setting set to ‘none’ and the reverse 234 
stranded option). Differential expression analysis was conducted in R using the DESeq2 235 
package [40]. 236 
 237 
Phage gene expression program was determined by normalising each gene by maximum and 238 
minimum expression levels then averaged across the 5 replicates of WT PA14 infected by 239 
DMS3vir. These profiles were clustered using the ‘hclust’ function in the R ‘stats’ package. 240 
A dendrogram was made with the ‘dendextend’ [41]. Sequence data is available from the 241 
European Nucleotide Archive under accession number PRJEB31514. 242 
 243 
Competition assays in the presence of Acr(-) phage 244 
In order to determine the effect of acrIE3 and aca1 gene expression on the fitness of immune 245 
hosts we competed a WT PA14 strain carrying 2 spacers that target DMS3vir (BIM2) against 246 
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a LacZ marked surface mutant in the presence of a phage lacking the full Acr operon and a 247 
WT control. While both of hosts are immune to DMS3vir, the surface mutant prevents phage 248 
genome injection and therefore any subsequent phage gene expression. Competition 249 
experiments were carried out as described above for 24 hours under with the addition of 105, 250 
107 and 109 PFU DMS3vir. 251 
 252 
ProI cloning and assay 253 
The protease I encoding gene from DMS3vir was cloned into the pHERD30T vector under 254 
control of an arabinose inducible promoter. The protease I encoding gene was amplified from 255 
DMS3vir via PCR and introduced into pHerd30T between an EcoRI and an XbaI site, 256 
downstream of an arabinose inducible promoter. Primers used for cloning are available in 257 
table S1. Colonies were selected using a gentamycin marker and blue/white colony screening 258 
in a background of DH5-alpha cells (New England Biolabs, UK).  The resulting construct 259 
was transformed into PA14 and the clone used for assays was verified by Sanger sequencing 260 
(University of Sheffield, UK). Optical density was recorded during a 24-hour growth curve at 261 
37 C in LB supplemented with 1% arabinose. Growth curves of the clone expressing the 262 
protease I encoding gene and an empty vector control were recorded. Growth rate during log-263 
phase was extracted from the growth curves in R (version 3.5.2).      264 
 265 
Results 266 
Fitness costs of CRISPR can select for alternative resistance strategies, and the subsequent 267 
invasion of bacteria carrying surface-based resistance [9]. However, it has remained unclear 268 
what the mechanistic basis of this cost is. We envisaged three possible reasons for this 269 
inducible cost: (i) a cost of autoimmunity, where bacteria acquire self-targeting spacers 270 
during infections (ii) a fitness cost due to enhanced expression of the CRISPR-Cas immune 271 
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system following infection or (iii) due to expression of phage-encoded genes in the period 272 
between phage genome injection and CRISPR-mediated clearance of the phage. To explore 273 
the first hypothesis, we first carried out an experiment where we infected WT PA14 daily 274 
with a high titer of phage DMS3vir, followed by deep sequencing of CRISPR amplicons to 275 
measure the frequency of self-targeting spacers. As expected, bacteria initially evolved high 276 
levels of CRISPR immunity with corresponding spacer acquisition, which was followed by a 277 
consistent increase in the frequency of surface mutants due to the induced fitness costs of 278 
CRISPR immunity in the presence of phage (Fig. 1). Deep sequencing of the CRISPR arrays 279 
from these bacterial populations revealed a corresponding decline in genetic diversity of 280 
CRISPR arrays (Fig.1). Because of primed spacer acquisition, most spacers target the phage 281 
DMS3vir genome in the area proximal to the priming site (position 27847), and the 282 
distribution of target sites on the phage genome is similar to that reported in previous studies 283 
on this empirical system (Fig. S1; [9, 27] as well of that of other empirical systems where 284 
primed spacer acquisition was observed [42–44]. Arrays carrying self-targeting spacers with 285 
either a canonical PAM site (n = 3) or a non-canonical PAM site (n = 3) to the original host-286 
genome were rare. Moreover, the majority of the spacers with a canonical PAM were only 287 
observed in a single sample, consistent with the idea that there is strong selection against a 288 
self-targeting spacer. These results therefore suggest that self-targeting is either deleterious or 289 
rare. By comparing the number of spacers acquired from the phage with either a canonical or 290 
non-canonical PAM site we estimated the background ratio between these acquisition events. 291 
By identifying the number of reads that mapped to arrays carrying self-targeting spacers with 292 
a non-canonical PAM, we can estimate the proportion of cells that self-target. We found that 293 
0.0068% of cells likely self-target (see SI for methods). As PAM sites are a key component of 294 
self-target avoidance, this further suggests the phenomenon is rare.  295 
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To explore whether these self-targeting events have a measurable negative impact on 296 
the fitness of the bacteria, we performed a competition experiment between a surface mutant 297 
and either WT bacteria with CRISPR immunity, which can acquire self-targeting spacers, or 298 
a cas1 deletion mutant with CRISPR immunity that is unable to acquire novel spacers. This 299 
competition was performed across a gradient of titres of DMS3mvir (a mutant of DMS3vir 300 
that is targeted by spacer1 in CRISPR array 2 of the PA14Δcas1 strain; hence both the 301 
surface mutant and competing bacterial genotypes are insensitive to this phage). If the 302 
induced fitness cost of CRISPR-Cas immunity was due to the acquisition of self-targeting 303 
spacers, we would expect the cas1 deletion mutant to have a higher relative fitness compared 304 
to the WT strain. However, this was not observed; the cas1 deletion mutant had a lower 305 
relative fitness than the WT strain during competition with the surface mutant (GLM, F1,70 = 306 
17.85, p < 0.001, Fig. 2). This is likely due to the evolution of escape phages that carry 307 
mutations in their target site, which the cas1 mutant cannot overcome. Indeed we found a 308 
higher number of escape phages evolving in the cas1 mutant compared to the WT strain at 309 
the high titre (108 PFU per mL) (GLM, F1,14 = 15.5, p < 0.01), but this was not observed at a 310 
lower phage titre (106 PFU per mL) (GLM, F1,15 = 2.2, p = 0.16). In summary these data 311 
show that, even at low phage titres when escape phages are likely to be extremely rare, the 312 
benefits of spacer acquisition outweigh any autoimmune effects. Taken together with the 313 
deep sequencing data, these results do not imply that the acquisition of self-targeting spacers 314 
is the primary driver of the observed phage-induced fitness cost that is associated with 315 
CRISPR immunity.  316 
To explore the second hypothesis, that the induced fitness cost is caused by induction 317 
of CRISPR-Cas gene expression, we performed RNAseq of uninfected controls as well as 318 
CRISPR immune bacteria infected with DMS3vir. To avoid evolution of “escape phage”, 319 
which carry mutations in the protospacer, we infected a CRISPR immune clone that carries 2 320 
 14
spacers targeting DMS3vir (BIM2), and extracted RNA at t=0, 35, 60 and 120 minutes post-321 
infection. BIM2 shows complete immunity to DMS3vir and no phage particles are produced 322 
following infection (limit of detection = 200 PFU / mL, data not shown; also see [11]). 323 
Differential expression analysis found no evidence that CRISPR-Cas expression is enhanced 324 
following infection (Fig. 3). Of all cas genes, only cas1 showed a significant difference, with 325 
slightly lower expression in infected BIM2 populations relative to controls (FDR adjusted p-326 
value = 0.017, log2 fold change =  - 0.375). These data therefore do not support the idea that 327 
the induced cost of CRISPR immunity observed in this experimental system is due to the 328 
upregulation of CRISPR-Cas expression.  329 
Interestingly, we identified a number of other host genes that showed significantly different 330 
gene expression in the infected BIM2 strain relative to the uninfected controls (Table S3).  331 
Across all 3 timepoints, genes involved in motility, polyamine breakdown and transport and 332 
metabolism were significantly upregulated. The two polyamines associated with phage 333 
infection were putrescine and spermidine which are linked to biofilm production (reviewed in 334 
[45]). In addition to these polyamines, we found many components of flagellum production 335 
to also be upregulated subsequent to phage infection including flagellar rod proteins and the 336 
flagellar motor switch. This suggests that bacteria are producing and activating flagella in 337 
response to infection. In contrast, we found a significant downregulation of many genes 338 
implicated in chemotaxis as well as oxidoreductases and cytochrome c genes and metabolism 339 
associated genes. These results suggest a shift in both the metabolism and motility of the 340 
bacteria in response to phage infection. Although the communication molecule PQS has 341 
previously been shown to be produced during phage infection in order to repel sensitive 342 
bacteria from the area [46] we found no significant upregulation of PQS genes. We also 343 
observed no obvious effect of time on host gene expression, with the most upregulated genes 344 
all occurring at similar levels throughout the experiment. 345 
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Finally, to test whether phage gene expression prior to clearance of the infection by 346 
the immune system could be responsible for the induced fitness cost, we measured whether 347 
phage gene expression could be detected in the infected BIM2 populations. To this end, we 348 
mapped all the RNAseq reads to the DMS3vir genome. This revealed significant levels of 349 
genome-wide phage gene expression in the BIM2 populations, despite their CRISPR-based 350 
immunity. In total, phage expression in the BIM2 populations was around 5-fold lower 351 
compared to infected WT populations (Fig. 4 and Fig. S2). Amongst the expressed phage 352 
genes, we identified very high expression levels of the anti-CRISPR (acrIE3) and its 353 
associated repressor (aca1) (Fig. S3), and to a lesser degree, many other genes (Fig S3). 354 
AcrIE3 and aca1 have previously been reported to be amongst the most strongly expressed 355 
genes on the phage DMS3vir genome [25]. This acrIE3 protein is specific for type I-E 356 
CRISPR-Cas systems and does not impact the type I-F CRISPR-Cas system encoded by 357 
PA14. Collectively, these data show that the phage is capable of expressing its genes prior to 358 
the completion of CRISPR mediated cleavage.  359 
To test whether expression of the acrIE3 or aca1 genes might contribute to the phage-360 
induced fitness cost that is observed in CRISPR-immune bacteria, we next competed the 361 
BIM2 strain and the surface mutant in the presence of either WT DMS3vir or a mutant 362 
carrying a deletion of the entire acr operon. This revealed a similar fitness cost of CRISPR 363 
immunity regardless of the phage genotype (GLM, effect of genotype on relative fitness of 364 
BIM vs SM, F1,34 = 2.00, p = 0.16), suggesting that the high expression levels of the acrIE3 365 
and aca1 genes is not causing the observed induced fitness cost in the host. However, given 366 
that many other phage genes are also expressed, albeit at lower levels, the induced cost may 367 
well be due to expression of one or more of these other phage genes.  368 
We next clustered the phage genes using their normalised gene expression during 369 
infection of WT PA14 (i.e. carries an imperfect CRISPR match which enables priming but 370 
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not immunity), following the methods of [47] (Fig. 5). We found that consistent with Stanley 371 
et al. [25] the acrIE3 and aca1 gene are expressed early. We also searched the annotations for 372 
potentially damaging genes and identified a protease I gene. Expression of the protease I gene 373 
might be particularly costly, since proteolytic activity could conceivably cause cytotoxicity in 374 
the cell. This gene is located immediately downstream of the acrIE3 and aca1 genes and was 375 
found to be expressed both in this experiment as well as a preliminary, independent RNAseq 376 
experiment using nanopore sequencing (data not shown). Given that protease I is involved in 377 
virion assembly, a deletion mutant would likely not be viable, we therefore cloned and 378 
expressed the protease gene in WT P. aeruginosa to measure the cost of expression of this 379 
gene for the host. This showed that protease I expression reduced cell growth rates by 380 
approximately 13% relative to an empty vector control (Fig. S4, GLM, F1, 46 = 28.72, p < 381 
0.001). This suggests that expression of phage genes prior to phage genome cleavage by the 382 
CRISPR-Cas immune system can be costly for the host. Given that this is just one of the 383 
many genes expressed by the phage during infection, we argue that phage gene expression 384 
prior to clearance of the infection is an important source of the observed phage-induced cost 385 
of CRISPR-based immunity.  386 
We developed a mathematical model to explore the competition between different 387 
resistant bacteria in the presence or in the absence of phages. Only the CRISPR immune 388 
bacteria are potentially affected by  the presence of phages because surface mutants cannot be 389 
infected. Our model shows that the dynamics we observe experimentally can be recreated 390 
even when self-targeting is absent, provided there is a cost associated with phage infection 391 
because of induced immunity or toxicity (see SI). Importantly, the model predicts that in the 392 
absence of a phage induced cost, bacteria with CRISPR-Cas systems that experience high 393 
levels of self-targeting would decline in frequency S5C). If the CRISPR immune bacteria is 394 
deficient in spacer acquisition (i.e. p=0) it would not decline in frequency (Fig. S5A). 395 
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However, this result is inconsistent with our experimental data, which shows that both 396 
bacteria with fully functional CRISPR immunity and those deficient in spacer acquisition 397 
lose the competition with surface mutants  (Fig. 2). Therefore, this model suggests the 398 




Previous work has demonstrated that CRISPR-immune populations experience infection-403 
dependent costs [9, 10]. Here, we test three hypotheses that might explain the observed 404 
infection-induced cost of CRISPR immunity. We find that upregulation of cas genes is 405 
unlikely to be the cause of this cost. While we cannot rule out increased cas protein activity 406 
levels, previous work found that plasmid targeting was unaffected by phage pre-infection 407 
[48]. Additionally, we find that autoimmunity due to acquisition of self-targeting spacers, 408 
although present, is unlikely to be an important source of the observed fitness costs of 409 
CRISPR immunity. Although quantifying the true extent of autoimmune effects of self-410 
targeting spacers is difficult as they, by definition, are rapidly lost from the populations, we 411 
also observe very low numbers of self-targeting spacers that target sequences with non-412 
canonical PAM. As these spacers would be selected against less strongly it supports the 413 
notion that self-targeting spacer acqusitions are rare [12]. Moreover, we see that carrying 414 
CRISPR in the absence of phages is not costly [9], that an acquisition-deficient mutant is 415 
equally fit to the wild-type in the absence of phages (Fig. 2), and there is no detectable 416 
difference in CRISPR-Cas expression in the presence or absence of phages (suggesting that 417 
rates of self-targeting spacer acquisition would be independent of the presence or absence of 418 
phage). This result is also consistent with previous studies that report higher rates of 419 
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acquisition from mobile genetic elements than the host genome, even in the absence of 420 
priming [13, 49].  421 
Our data demonstrate that there are high levels of phage gene expression following 422 
infection, even with highly effective CRISPR targeting. Phage gene expression likely creates 423 
cytotoxic effects for the infected bacterial cells and host gene expression is fundamentally 424 
altered. The finding that phages can rapidly express their genes prior to clearance by the 425 
CRISPR-Cas immune system is consistent with previous studies [25]. For example, phages 426 
that encode acr genes can successfully infect bacteria with CRISPR immunity, even though 427 
the Acr proteins are produced during the infection cycle. This has selected for extremely 428 
rapid and strong expression of the acr gene (acrIE3) and its repressor (aca1) [25], which we 429 
also observed in our RNAseq data. These high expression levels of the acrIE3 gene, which 430 
targets Type I-E CRISPR-Cas immune systems and not the Type I-F system of the PA14 431 
strain used here, was not associated with a detectable cost. However, we found genome-wide 432 
phage gene expression suggesting multiple opportunities for phage mediated damage prior to 433 
clearance (Fig S4). We also found that plasmid-based expression of a phage gene (protease I) 434 
showed cytotoxicity and may be cleaving host proteins as well as performing its likely role in 435 
capsid packaging [50]. We suggest this may be representative of a widespread cost of phage 436 
gene expression and further work is needed to assess the point at which phage DNA no 437 
longer has a negative effect on the host cell. Given that, in some cases, the CRISPR immune 438 
system preferentially targets the portion of the phage genome that is injected into the cell 439 
first, it appears that preventing phage gene expression as soon as possible is crucial for 440 
immunity [51]. Understanding the exact timing of CRISPR interference remains a vital 441 
question as the effects of targeting during different parts of the phage replication cycle may 442 
be important for the efficiency of immune response. Indeed similar effects may also occur 443 
during anti-plasmid immunity, when a plasmid carries genes that are toxic to the host [52]. In 444 
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addition to the protease we identified a number of host processes that are induced upon phage 445 
infection, which may further contribute to the observed infection-induced fitness cost of 446 
CRISPR immune bacteria. Notably the export of spermidine, breakdown of putrescine and 447 
construction and activation of flagella may all lead to intrinsic energetic costs. It is unclear 448 
why these host processes are induced and their adaptive significance. Given that 449 
Pseudomonas phages appear unable to replicate on hosts deficient for spermidine production 450 
[53], export of spermidine would likely interfere with phage propagation. The upregulation of 451 
degradation and export of these polyamines is interesting as polyamine production has been 452 
linked to biofilm production and protection from antibiotics- exogenous polyamines may also 453 
confer a protective barrier against phages. It is also possible that the change in host processes 454 
is a manipulation from the phage, analogous to some eukaryotic viruses that enhance host 455 
movement during infection in order to facilitate greater virus dispersal (reviewed in [54]). In 456 
this context the phage could induce flagella-based motility in order to disseminate virions to a 457 
wider area. An alternative is that flagella production is a host response to leave an area of 458 
high relatedness and therefore limit subsequent infections to kin. Such movement away from 459 
infected populations has been previously observed in Pseudomonas aeruginosa [46] and 460 
motility has been shown to confer a fitness advantage in the presence of phages- although the 461 
precise mechanism is unclear [55]. 462 
In addition to the effects we observed, there may be additional unknown factors that 463 
arise from phage infection. These could include cellular stress from membrane piercing 464 
during phage injection, or the costs of producing phage proteins even if they are not 465 
cytotoxic. Similarly, Mu-like phages replicate via replicative transposition, which involves 466 
integrated into the genome during the lytic cycle, and it is possible that CRISPR targeting of 467 
the phage during this step would be costly to the host. Such targeting during lysogenic 468 
infection has been observed to result in the upregulation of the SOS response [56] and can 469 
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lead to the loss of a functional CRISPR system [8]. Although we do not see significant 470 
upregulation of the genes associated with this response, we cannot rule out this effect from 471 
happening in a sub-population of cells (< 1% based on the effect sizes seen in Heussler et al. 472 
[56]). As more phage defences are discovered and described it will be fascinating to see how 473 
their specific costs and benefits will compare to CRISPR and other well described 474 
mechanisms, such as restriction modification. For example, the lag between infection and 475 
detection may represent a widespread cost intrinsic to all post-infection defence systems. Our 476 
results suggest that although the maintenance of a CRISPR system is likely to be low-cost, 477 
the infection-dependent cost is likely to be much higher. Therefore, if the frequency of phage 478 
challenge is high, constitutive mechanisms are selected for. Moreover, the interplay between 479 
costs and benefits may vary by environment [57]. For example, in our liquid media 480 
experiments, spatial structure is absent, or low, which may reduce the requirement for a pilus 481 
(the DMS3vir receptor). In a highly structured environment, such trade-offs may differ. More 482 
generally, the ecological context will influence how costly it is to lose the pilus, for example 483 
coexistence with other bacteria can amplify the costs [58]. In turn, these results may help 484 
explain the patchy distribution of CRISPR systems observed in nature as different niches will 485 
be associated with varying trade-offs and infection risks. Indeed it is increasingly understood 486 
that CRISPR systems may be transferred among bacteria leading to the frequent gain and loss 487 
of such systems. This may, in part, be driven by the relative cost - benefit relationship 488 
between inducible cost and infection frequency [59].  489 
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Figure Legends 673 
 674 
Figure 1. 675 
Population dynamics of each bacterial genotype and phage titres. A) Each point represents 676 
the proportion of bacterial phenotypes (n = 24 clones per population) that exist in each 677 
population. Shaded lines represent individual populations. Dashed lines represent model fit 678 
from a GLM that includes a polynomial spline (knots = 2). B) Lines represent the phage titres 679 
present in each population throughout the evolution experiment. C) Genetic diversity 680 
(Shannon’s diversity index) of the CRISPR 2 array during the first 12 days of the experiment 681 
from amplicon sequence data.  682 
 683 
 684 
Figure 2. 685 
Relative fitness of bacterial populations with CRISPR-mediated immunity at 3 d.p.i. when 686 
competing with a surface mutant. Competitions were carried out between a marked surface 687 
resistant strain and either the WT PA14 (purple), a mutant PA14 lacking a functional cas1 688 
(orange) or a WT-derived strain carrying 2 additional spacers targeting phage DMS3mvir 689 
(BIM2; green). Experiments were carried out across a gradient of phage titres, as indicated.  690 
The phage used (DMS3mvir) is a mutant of DMS3vir that is targeted by WT PA14. N = 8 691 
replicates per genotype per phage titre. A) Data presented with phage titre as a continuous 692 






Fig. 3 698 
Expression of CRISPR associated genes following infection with 8 X 10^9 PFU DMS3vir 699 
(MOI 0.5) across PA14 WT (purple, n = 5), PA14 BIM2 (orange, n = 5) and PA14 BIM2 700 








Fig. 4  709 
Total phage gene expression following infection with 8 X 10^9 PFU DMS3vir (MOI 0.5) 710 
across PA14 WT (green, n = 5), PA14 BIM2 (blue, n = 5) and PA14 BIM2 uninfected 711 
controls (red, n = 5). Samples taken 35, 60 and 120 minutes post-infection.  712 
 713 
 714 
Fig. 5. Normalised phage gene expression of DMS3vir infecting WT PA14. Normalised gene 715 
expression was averaged across replicates (n = 5 per time point) and grouped by hierarchical 716 
clustering to identify distinct phases of the transcriptional program. A) Dendrogram showing 717 
discrete clusters with annotated genes and hypothetical proteins (numbered). B) Normalised 718 
gene expression of each gene through time grouped by each cluster. Lines show local-719 
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